This study proved that VD3 decreased breast cancer cell viability along with reduced expression of GLUT1 and key glycolytic enzymes (hexokinase II and lactate dehydrogenase A), causing a decrease in glucose uptake. This evidence concerns the gene SLC2A1 and breast carcinoma.